Overview
ELV market data
Price History
ELV price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ELV. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Leerink Partners Maintains Market Perform on Elevance Health, Raises Price Target to $395Benzinga · Jul 17, 2026, 6:15 PM
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage LossesBenzinga · Jul 16, 2026, 5:24 PM
RBC Capital Maintains Sector Perform on Elevance Health, Lowers Price Target to $424Benzinga · Jul 16, 2026, 3:03 PM
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $473Benzinga · Jul 16, 2026, 2:52 PM
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel ItBenzinga · Jul 16, 2026, 1:24 PM
These Analysts Revise Their Forecasts On Elevance Health Following Q2 EarningsBenzinga · Jul 16, 2026, 12:17 PM
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $455Benzinga · Jul 16, 2026, 12:02 PM
Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $457Benzinga · Jul 16, 2026, 11:38 AM
Baird Maintains Neutral on Elevance Health, Raises Price Target to $393Benzinga · Jul 16, 2026, 11:15 AM
Elevance Health's Small Outlook Boost Disappoints, Stock SinksBenzinga · Jul 15, 2026, 2:22 PM